Moneycontrol

Budget 2023Budget 2023

PARTNERS

  • Tata AIA Life Insurance
  • Hafele
  • Motilal Oswal
  • SMC Global Securities Limited
  • SBI Life
  • DSP Mutual Fund
Upcoming Event : LeapToUnicorn - mentoring, networking and fundraising for startups. Register now
you are here: HomeNewsIndia

Coronavirus pandemic | This Indian company's test kits have received commercial approval

The company said it can manufacture 1 lakh test kits a week, but can ramp up production if required

March 24, 2020 / 07:31 PM IST


Pune-based Mylab Discovery Solutions is the first Indian company to receive commercial approval for its novel coronavirus, or COVID-19, testing kits.

The testing kit has been approved by the Indian FDA/Central Drugs Standard Control Organisation (CDSCO), the molecular diagnostics company said in a release.

The move will help increase testing in India, where the number of samples being tested is still small.

One unit of the Mylab PathoDetect COVID-19 Qualitative PCR kit can test 1oo patients. The company said it can manufacture 1 lakh test kits a week, but can ramp up production if required.


  Mylab, founded in 2016, describes itself as a "young and dynamic biotechnology company that develops and commercialises molecular diagnostic detection kits."
The company, which has 150 products, has experience in manufacturing ID-NAT screening kits for blood banks/hospitals, Quantitative HIV, HBV and HCV kits. It sells the ID-NAT screening kits under the brand name 'NATSpert'.